PTC414, an analogue of PTC124, was evaluated for its ability to target nonsense mutations and restore Rab Escort Protein 1 (REP1) function in both primary human fibroblasts and a zebrafish model of choroideremia, demonstrating greater effectiveness and improved pharmacokinetic characteristics when compared to PTC124. This evidence concerns the gene CHM and choroideremia.